drugset / Trial / NCT00226343

Depakote-ER for Depressive and Bipolar Depression

NCT00226343

RandomizedParallel-groupDouble-blindTreatment

Summary

Obtain information using a randomized treatment to assess the antidepressant and anxiolytic efficacy of divalproex vs. placebo for nonrefractory bipolar patients with major depressive episodes.

Timeline

Start
2003-08
Primary completion
2006-01
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Valproate Small molecule

Indications